SCHEMBL7222151

SCHEMBL7222151

C=CC(OC(C)=O)c1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
KDM4E B2RXH2 1/20 0.39
CNR2 P34972 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222153 1.00 HDAC4 (0.43) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL28691333 0.87 HDAC4 (0.45) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL23059516 0.86 HDAC4 (0.44) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL6752515 0.83 LMNA (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL27913950 0.82 TGM2 (0.39) ALDH1A1CYP3A4IDO1TDO2
SCHEMBL8148870 0.81 CES2 (0.46) CES2ALDH1A1CYP3A4IDO1TDO2
SCHEMBL61038 0.80 CYP3A4 (0.50) KDM4EALDH1A1CYP3A4CYP2C19
SCHEMBL28772383 0.80 HDAC4 (0.46) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL28446132 0.79 IDO1 (0.43) HDAC4HDAC7HDAC5CES2CES1
SCHEMBL19881211 0.78 HDAC4 (0.47) HDAC4HDAC7HDAC5CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6593346-B2 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3. MERCK & CO. INC. 2003-07-15 US disclosed
US-6358979-B1 FOR THERAPY AND PROPHYLAXIS OF ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS OR RHEUMATOID ARTHRITIS, INFECTION BY HIV, TREATING INFECTION BY HIV, DELAYING OF THE ONSET OF AIDS MERCK & CO., INC. 2002-03-19 US disclosed